Massachusetts Financial Services
ACAD icon

Massachusetts Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Massachusetts Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6M Sell
855,435
-164,389
-16% -$3.62M 0.01% 654
2026
Q1 		$22.7M Sell
1,019,824
-52,659
-5% -$1.26M 0.01% 615
2025
Q4 		$28.6M Sell
1,072,483
-38,243
-3% -$914K 0.01% 586
2025
Q3 		$23.7M Buy
1,110,726
+1,052,038
+1,793% +$24.9M 0.01% 607
2025
Q2 		$1.27M Buy
58,688
+725
+1% +$13.5K ﹤0.01% 798
2025
Q1 		$963K Sell
57,963
-1,320
-2% -$24K ﹤0.01% 810
2024
Q4 		$1.09M Sell
59,283
-1,768
-3% -$28.5K ﹤0.01% 814
2024
Q3 		$939K Sell
61,051
-1,479
-2% -$24.7K ﹤0.01% 801
2024
Q2 		$1.02M Buy
62,530
+2,100
+3% +$33.9K ﹤0.01% 798
2024
Q1 		$1.12M Sell
60,430
-134
-0.2% -$3.32K ﹤0.01% 780
2023
Q4 		$1.9M Buy
+60,564
New +$1.45M ﹤0.01% 729
2018
Q2 		– Sell
-248,233
Closed -$5.58M – 839
2018
Q1 		$5.58M Buy
248,233
+66,283
+36% +$1.84M ﹤0.01% 658
2017
Q4 		$5.48M Buy
181,950
+2,414
+1% +$77.2K ﹤0.01% 659
2017
Q3 		$6.76M Buy
179,536
+1,096
+0.6% +$35.7K ﹤0.01% 643
2017
Q2 		$4.98M Sell
178,440
-35
-0% -$1.04K ﹤0.01% 673
2017
Q1 		$6.14M Sell
178,475
-266
-0.1% -$9.39K ﹤0.01% 636
2016
Q4 		$5.16M Sell
178,741
-429
-0.2% -$11.3K ﹤0.01% 658
2016
Q3 		$5.7M Sell
179,170
-59,517
-25% -$2.02M ﹤0.01% 634
2016
Q2 		$7.75M Buy
238,687
+42,720
+22% +$1.43M ﹤0.01% 599
2016
Q1 		$5.48M Buy
+195,967
New +$4.27M ﹤0.01% 632

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Massachusetts Financial Services's ACAD Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Acadia Pharmaceuticals (ACAD) stake by 16% in Q2 2026, selling an estimated $3.62M and leaving 855,435 shares worth $21.6M. The position accounts for 0.01% of the portfolio, ranked #654.

Massachusetts Financial Services first reported a position in ACAD in Q1 2016 and has held it in 20 quarters since. The position peaked at $28.6M in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Massachusetts Financial Services held 855,435 shares of Acadia Pharmaceuticals worth $21.6M as of Q2 2026.
  • Massachusetts Financial Services sold 164,389 Acadia Pharmaceuticals shares in Q2 2026, an estimated $3.62M.
  • Acadia Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #654 holding.
  • Massachusetts Financial Services first reported a position in Acadia Pharmaceuticals in Q1 2016 and has held it in 20 quarters since.
  • Massachusetts Financial Services's Acadia Pharmaceuticals position peaked at $28.6M in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.